Overview

AgenT Biotech develops a platform for early cancer detection that combines advanced biosensors with artificial intelligence to identify cancer biomarkers quickly and accurately. The system collects biological signals with biosensors and uses AI to analyze complex data, spotting patterns that indicate cancer at an early stage. The product is designed to be more accurate and faster than current methods, enabling earlier treatment decisions. The company differentiates itself by integrating biosensing technology with AI in a single platform, which can be commercialized through partnerships with healthcare providers, licensing, or selling diagnostic kits. The goal is to improve patient outcomes by enabling earlier and more effective cancer treatment and, potentially, reduce healthcare costs through earlier intervention.